sponsored
PatientsVille.com Logo

PatientsVille

Neurontin and Flagyl

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectNeurontinFlagyl
DRUG INEFFECTIVE4.6% 2.4%
DIARRHOEA2.3% 3.6%
NAUSEA3% 3.4%
DRUG HYPERSENSITIVITY1.8% 3.2%
FATIGUE3.1% 1.9%
PAIN2.9% 2.3%
VOMITING1.6% 2.7%
PYREXIA1.1% 2.6%
HEADACHE2.3% 2%
DIZZINESS2.3% 1.9%
FALL2.2% 0.8%
DYSPNOEA2% 2%
ABDOMINAL PAIN0.8% 2%
ASTHENIA1.7% 1.5%
PAIN IN EXTREMITY1.7% 1.1%
RASH1.1% 1.7%
MALAISE1.6% 1.4%
DEPRESSION1.6% 1%
ANXIETY1.4% 1.5%
INSOMNIA1.5% 0.9%
PNEUMONIA1.4% 1.2%
ARTHRALGIA1.4% 1.1%
SOMNOLENCE1.4% 0.7%
OFF LABEL USE1.3% 1%
BACK PAIN1.3% 0.8%
HYPOTENSION0.8% 1.3%
GAIT DISTURBANCE1.3% 0.7%
ANAEMIA0.7% 1.3%
FEELING ABNORMAL1.3% 0.6%
WEIGHT DECREASED1.2% 1.1%
CONFUSIONAL STATE1% 1.2%
PRURITUS1% 1.2%
DEATH1.2% 0.9%
DRUG INTERACTION0.7% 1.2%
SEPSIS0.5% 1.2%
CONDITION AGGRAVATED1.1% 1%
PARAESTHESIA0.9% 1.1%
HYPOAESTHESIA1.1% 0.8%
RENAL FAILURE0.7% 1.1%
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION1.1% 0%
WEIGHT INCREASED1.1% 0%
CONSTIPATION1% 0.7%
DEHYDRATION0.7% 1%
ABDOMINAL PAIN UPPER0.7% 1%
TREMOR1% 0.6%
ACUTE KIDNEY INJURY0.6% 1%
MUSCLE SPASMS1% 0.6%
COMPLETED SUICIDE1% 0%
INJURY0% 1%
CLOSTRIDIUM DIFFICILE INFECTION0% 1%
THROMBOCYTOPENIA0% 1%
DRUG DOSE OMISSION1% 0%
CHEST PAIN0.9% 0.9%
DECREASED APPETITE0.8% 0.9%
NEUROPATHY PERIPHERAL0.9% 0.8%
URINARY TRACT INFECTION0.9% 0.8%
HYPERTENSION0.9% 0.8%
MEMORY IMPAIRMENT0.9% 0%
OEDEMA PERIPHERAL0.8% 0.7%
COUGH0.8% 0.7%
TOXICITY TO VARIOUS AGENTS0.8% 0.6%
ERYTHEMA0.5% 0.8%
CLOSTRIDIUM DIFFICILE COLITIS0% 0.8%
PULMONARY EMBOLISM0% 0.8%
NEUTROPENIA0% 0.8%
URTICARIA0% 0.8%
HYPERSENSITIVITY0.5% 0.7%
MUSCULAR WEAKNESS0.7% 0.5%
INFECTION0.4% 0.7%
VISION BLURRED0.7% 0%
BALANCE DISORDER0.7% 0%
RENAL FAILURE ACUTE0% 0.7%
SEPTIC SHOCK0% 0.7%
SUICIDAL IDEATION0.7% 0%
TACHYCARDIA0% 0.7%
DEEP VEIN THROMBOSIS0% 0.7%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.7%
PERIPHERAL SWELLING0.7% 0%
RESPIRATORY FAILURE0% 0.7%
LOSS OF CONSCIOUSNESS0.7% 0%
MYALGIA0.6% 0.6%
ABDOMINAL DISCOMFORT0.6% 0.5%
CHILLS0.4% 0.6%
DYSPHAGIA0.4% 0.6%
PANCYTOPENIA0% 0.6%
HAEMOGLOBIN DECREASED0% 0.6%
DYSGEUSIA0% 0.6%
HAEMORRHAGE0% 0.6%
ALANINE AMINOTRANSFERASE INCREASED0% 0.6%
EMOTIONAL DISTRESS0% 0.6%
ABDOMINAL DISTENSION0% 0.6%
PATHOGEN RESISTANCE0% 0.6%
PLEURAL EFFUSION0% 0.6%
COLITIS0% 0.6%
ATRIAL FIBRILLATION0% 0.6%
DIVERTICULITIS0% 0.6%
CROHN^S DISEASE0% 0.6%
BLOOD GLUCOSE INCREASED0.6% 0%
MULTIPLE SCLEROSIS RELAPSE0.6% 0%
AMNESIA0.6% 0%
OVERDOSE0.6% 0%
INJECTION SITE PAIN0.6% 0%
HYPERHIDROSIS0.6% 0%
MYOCARDIAL INFARCTION0.6% 0%
ALOPECIA0.6% 0%
CEREBROVASCULAR ACCIDENT0.6% 0%
PRODUCT USE ISSUE0.6% 0%
SYNCOPE0.4% 0.5%
GASTROINTESTINAL HAEMORRHAGE0.4% 0.5%
ANAPHYLACTIC REACTION0% 0.5%
CHOLELITHIASIS0% 0.5%
DYSARTHRIA0% 0.5%
TOXIC ENCEPHALOPATHY0% 0.5%
INTERNATIONAL NORMALISED RATIO INCREASED0% 0.5%
PALPITATIONS0% 0.5%
CARDIAC ARREST0% 0.5%
ENCEPHALOPATHY0% 0.5%
FEBRILE NEUTROPENIA0% 0.5%
ASPARTATE AMINOTRANSFERASE INCREASED0% 0.5%
HYPOKALAEMIA0% 0.5%
CARDIAC FAILURE CONGESTIVE0.5% 0%
NASOPHARYNGITIS0.5% 0%
BLOOD PRESSURE INCREASED0.5% 0%
CONVULSION0.5% 0%
CONTUSION0.5% 0%
BURNING SENSATION0.5% 0%
PRODUCT USE IN UNAPPROVED INDICATION0.5% 0%
DIABETES MELLITUS0.5% 0%
SUICIDE ATTEMPT0.4% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.4% 0%
HALLUCINATION0.4% 0%
JOINT SWELLING0.4% 0%
FLUSHING0.4% 0%
BRONCHITIS0.4% 0%
DRY MOUTH0.4% 0%
MIGRAINE0.4% 0%
WHITE BLOOD CELL COUNT DECREASED0.4% 0%

New treatments are found every day. View current Neurontin research studies and Flagyl clinical trials

1